Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dimenhydrinate
Drug ID BADD_D00676
Description Dimehydrinate was first described in the literature in 1949,[A233120] and patented in 1950.[L32995] Early research into dimenhydrinate focused on its role as an antihistamine for urticaria; the treatment of motion sickness was an accidental discovery.[A233130] Dimenhydrinate, also known as B-dimethylaminoethyl benzohydrol ether 8-chlorotheophyllinate, is indicated to prevent nausea, vomiting, and dizziness caused by motion sickness.[L32980,L32985,L32995] Dimenhydrinate is a combination of [Diphenhydramine] and [8-chlorotheophylline] in a salt form, with 53%-55.5% dried diphenhydramine, and 44%-47% died 8-chlorotheophylline.[L32985] The antiemetic properties of dimenhydrinate are primarily thought to be produced by diphenhydramine's antagonism of H1 histamine receptors in the vestibular system[A1540] while the excitatory effects are thought to be produced by 8-chlorotheophylline's adenosine receptor blockade.[A33889] When used in large doses, dimenhydrinate has been shown to cause a "high" characterized by hallucinations, excitement, incoordination, and disorientation.[A1539] Dimenhydrinate was granted FDA approval on 31 May 1972.[L32975]
Indications and Usage Used for treating vertigo, motion sickness, and nausea associated with pregnancy.
Marketing Status Prescription; Discontinued
ATC Code R06AA11
DrugBank ID DB00985
KEGG ID D00520
MeSH ID D004111
PubChem ID 10660
TTD Drug ID D0U8UV
NDC Product Code 12711-4675; 63941-198; 10237-942; 0924-1006; 70000-0404; 11673-198; 63868-034; 10267-1006; 69842-206; 46122-536; 55745-0002; 10237-941; 0363-0198; 29485-6925; 0924-1007; 50804-198; 66715-9809; 49452-2615; 63029-902; 63029-910; 52904-962; 51927-1080; 59779-198; 0904-6772; 36800-930; 49873-802; 0904-2051; 63029-901; 10267-4186; 11822-0198; 10267-4215; 64092-600; 0363-1980; 29485-8048; 63323-366; 10237-940; 50844-199; 49035-981; 29485-1216; 62011-0341; 67751-170; 67091-118; 70677-0022
Synonyms Dimenhydrinate | Diphenhydramine Theoclate | Theoclate, Diphenhydramine | Wehamine | Aviomarin | Biodramina | Calm-X | Calm X | Cinfamar | Contramareo | Dimen Heumann | Heumann, Dimen | Dimen Lichtenstein | Lichtenstein, Dimen | Dimetabs | Dinate | DMH | Dramanate | Gravol | Marmine | Motion-Aid | Motion Aid | Nausicalm | Reisegold | Reisetabletten Lünopharm | Lünopharm, Reisetabletten | Reisetabletten Stada | Stada, Reisetabletten | Reisetabletten-ratiopharm | Reisetabletten ratiopharm | Rodovan | RubieMen | Superpep | Travel Well | TripTone | Vertigo-Vomex | Vertigo Vomex | Vomex A | Vomacur | Vomisin | Dramamine | Apo-Dimenhydrinate | Apo Dimenhydrinate
Chemical Information
Molecular Formula C17H21NO.C7H7ClN4O2
CAS Registry Number 523-87-5
SMILES CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation19.06.02.001; 17.02.05.012--
Dermatitis23.03.04.002--Not Available
Dizziness17.02.05.003; 02.01.02.004; 24.06.02.007--
Dry mouth07.06.01.002--
Dry throat22.02.05.004; 07.06.01.005--Not Available
Dyspepsia07.01.02.001--
Dysuria20.02.02.002--
Fatigue08.01.01.002--
Headache17.14.01.001--
Insomnia19.02.01.002; 17.15.03.002--
Nasal dryness22.04.03.002--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Rash23.03.13.001--Not Available
Restlessness19.11.02.002; 17.02.05.021--
Somnolence19.02.05.003; 17.02.04.006--
Tachycardia02.03.02.007--Not Available
Tension19.06.02.005--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Epigastric discomfort07.01.02.004--Not Available
Decreased appetite08.01.09.028; 14.03.01.005--
Increased bronchial secretion22.02.04.007--Not Available
The 1th Page    1    Total 1 Pages